BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 15475071)

  • 1. Methylation status of cyclin-dependent kinase inhibitor genes within the transforming growth factor beta pathway in human T-cell lymphoblastic lymphoma/leukemia.
    Scott SA; Kimura T; Dong WF; Ichinohasama R; Bergen S; Kerviche A; Sheridan D; DeCoteau JF
    Leuk Res; 2004 Dec; 28(12):1293-301. PubMed ID: 15475071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1/WAF1 and p27Kip1.
    Flørenes VA; Bhattacharya N; Bani MR; Ben-David Y; Kerbel RS; Slingerland JM
    Oncogene; 1996 Dec; 13(11):2447-57. PubMed ID: 8957087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermethylation of the cell cycle inhibitor p15INK4b 3'-untranslated region interferes with its transcriptional regulation in primary lymphomas.
    Malumbres M; Pérez de Castro I; Santos J; Fernández Piqueras J; Pellicer A
    Oncogene; 1999 Jan; 18(2):385-96. PubMed ID: 9927195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R; Shiohara M; Koeffler HP; Fagin JA
    Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2.
    Joyce NC; Harris DL; Mello DM
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2152-9. PubMed ID: 12091410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation of promoter region in p27 gene plays a role in the development of lymphoid malignancies.
    Nakatsuka S; Liu A; Yao M; Takakuwa T; Tomita Y; Hoshida Y; Nishiu M; Aozasa K
    Int J Oncol; 2003 Mar; 22(3):561-8. PubMed ID: 12579309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.
    Herman JG; Jen J; Merlo A; Baylin SB
    Cancer Res; 1996 Feb; 56(4):722-7. PubMed ID: 8631003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over-expression of CDKIs p15INK4b, p16INK4a and p21CIP1/WAF1 genes mediate growth arrest in human osteosarcoma cell lines.
    Agiostratidou G; Derventzi A; Gonos ES
    In Vivo; 2001; 15(5):443-6. PubMed ID: 11695244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Universal inactivation of both p16 and p15 but not downstream components is an essential event in the pathogenesis of T-cell acute lymphoblastic leukemia.
    Omura-Minamisawa M; Diccianni MB; Batova A; Chang RC; Bridgeman LJ; Yu J; Pullen J; Bowman WP; Yu AL
    Clin Cancer Res; 2000 Apr; 6(4):1219-28. PubMed ID: 10778944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
    Iolascon A; Della Ragione F; Giordani L; Serra A; Saglio G; Faienza MF
    Haematologica; 1998 Sep; 83(9):771-7. PubMed ID: 9825572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation analysis of cyclin-dependent kinase inhibitor genes in primary gastrointestinal lymphomas.
    Go JH
    Mod Pathol; 2003 Aug; 16(8):752-5. PubMed ID: 12920218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias.
    Chim CS; Wong AS; Kwong YL
    Ann Hematol; 2003 Dec; 82(12):738-42. PubMed ID: 14513284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of Smad3 in acute T-cell lymphoblastic leukemia.
    Wolfraim LA; Fernandez TM; Mamura M; Fuller WL; Kumar R; Cole DE; Byfield S; Felici A; Flanders KC; Walz TM; Roberts AB; Aplan PD; Balis FM; Letterio JJ
    N Engl J Med; 2004 Aug; 351(6):552-9. PubMed ID: 15295048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia.
    Batova A; Diccianni MB; Yu JC; Nobori T; Link MP; Pullen J; Yu AL
    Cancer Res; 1997 Mar; 57(5):832-6. PubMed ID: 9041181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines.
    Fujishita T; Mizushima Y; Kashii T; Kobayashi M
    Anticancer Res; 1998; 18(3A):1537-42. PubMed ID: 9673367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant p27Kip1 promoter methylation in malignant melanoma.
    Worm J; Bartkova J; Kirkin AF; Straten P; Zeuthen J; Bartek J; Guldberg P
    Oncogene; 2000 Oct; 19(44):5111-5. PubMed ID: 11042700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cyclin-dependent kinase inhibitors p27Kip1 and p21Cip1 are not essential in T cell anergy.
    Verdoodt B; Blazek T; Rauch P; Schuler G; Steinkasserer A; Lutz MB; Funk JO
    Eur J Immunol; 2003 Nov; 33(11):3154-63. PubMed ID: 14579284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of tumor suppressor genes in the development of adult T cell leukemia/lymphoma (ATLL).
    Hatta Y; Koeffler HP
    Leukemia; 2002 Jun; 16(6):1069-85. PubMed ID: 12040438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of the INK4 family of cyclin-dependent kinase inhibitors by tax protein of HTLV-1 through two distinct mechanisms.
    Suzuki T; Narita T; Uchida-Toita M; Yoshida M
    Virology; 1999 Jul; 259(2):384-91. PubMed ID: 10388662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation of the multi tumor suppressor gene-2 (MTS2, CDKN1, p15INK4B) in childhood acute lymphoblastic leukemia.
    Iravani M; Dhat R; Price CM
    Oncogene; 1997 Nov; 15(21):2609-14. PubMed ID: 9399648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.